MedPath

The Concord Repatriation General Hospital Intensive Care Quality of Care Study

Conditions
End-of-life care in the ICU
Other - Research that is not of generic health relevance and not applicable to specific health categories listed above
Registration Number
ACTRN12606000110583
Lead Sponsor
Concord Repatriation General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
180
Inclusion Criteria

1. Patient has a pre-terminal or terminal condition and the treating ICU physician, and parent treating teams believe that continuing current treatment or escalating treatment is futile, and unlikely to alter the overall outcome. 2. The ICU physician deems it appropriate that a Not-For-Resuscitation (NFR) order be written for the patient. 3. The patient is unlikely to survive more than 1 week if treatment is either not escalated, or treatment is withdrawn. 4. The patient is expected to stay in the ICU for at least another 2 days. 5. A palliative care team is available to be involved in end-of-life care within the following 24 hours. 6. Patient or surrogate is willing to consent to completing the two questionnaires to be administered during the palliation process. 7. There is no reason to believe that the patient or family would object to palliative care team involvement in the patient’s end-of-life care.

Exclusion Criteria

1 The patient is unable to give consent or participate in the decision-making process, and has no readily available legal surrogate decision-maker, or is under Guardianship Board control.2 A palliative care team is not available to see the patient within the next 24 hours.3 The patient is not likely to survive to palliative care team review.4 The patient or surrogates, or treating medical teams have already specifically requested palliative care involvement in end-of-life care.5 No independent intensive care consultant is available to approach family for consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath